Form 4: GoodRx Holdings to Repurchase $44.9 Million in Class A Common Stock from Spectrum Equity

GoodRx Holdings will repurchase shares from Spectrum Equity VII, L.P., Spectrum VII Investment Managers' Fund, L.P., and Spectrum VII Co-Investment Fund L.P. for approximately $44.9 million.

Summary

• GoodRx Holdings, Inc. will repurchase 6,239,942 shares of Class A Common Stock from Spectrum Equity VII, L.P., Spectrum VII Investment Managers' Fund, L.P., and Spectrum VII Co-Investment Fund L.P.
• The aggregate purchase price for the shares is $44,865,182.98, equating to a price of $7.19 per share.
• The selling stockholders are converting an aggregate of 6,239,942 shares of Class B Common Stock into Class A Common Stock on a one-for-one basis in connection with the repurchase.
• The transaction is expected to close on March 11, 2024.
• Following the transaction, Spectrum Equity VII, L.P. will beneficially own 29,825,306 shares, Spectrum VII Investment Managers' Fund, L.P. will beneficially own 51,051 shares, and Spectrum VII Co-Investment Fund L.P. will beneficially own 28,776 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard transaction (stock repurchase) with no clear positive or negative implications without further context.

Positives

• The repurchase could be seen as a positive signal, indicating that GoodRx believes its stock is undervalued.
• The transaction simplifies the capital structure by reducing the number of Class B shares.

Future Outlook

The reported amounts give effect to the closing of the Repurchase, which is expected to occur on March 11, 2024.

Industry Context

Stock repurchases are a common way for companies to return capital to shareholders, especially when they believe their stock is undervalued. Private equity firms like Spectrum Equity often reduce their stakes in portfolio companies over time.

Comparison to Industry Standards

• Stock repurchases are a common capital allocation strategy, often compared to dividend payouts or acquisitions.
• The size of the repurchase relative to GoodRx's market capitalization would be a key metric to compare against industry peers.
• Similar transactions involving private equity firms selling stakes in publicly traded companies are frequent, and the terms (pricing, timing) are often compared.

Related Party Transactions

• The stock repurchase from Spectrum Equity VII, L.P., Spectrum VII Investment Managers' Fund, L.P., and Spectrum VII Co-Investment Fund L.P. constitutes a related party transaction.

Stakeholder Impact

• Shareholders may view the repurchase positively if they believe it will increase the value of their remaining shares.
• The impact on employees, customers, suppliers, and creditors is likely to be minimal.

Key Dates